Trial Profile
A phase I study to evaluate Ceclazepide
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2018
Price :
$35
*
At a glance
- Drugs Ceclazepide (Primary)
- Indications Gastro-oesophageal reflux; Helicobacter infections; Neuroendocrine tumours
- Focus Adverse reactions
- 06 Mar 2018 New trial record